In contrast, of 23 patients bearing a tumor with diploid CNV of BECN1 and BRCA1 only 11 (48%) were sensitive, 6 (26%) developed resistance and 6 (26%) developed an early resistance, as shown in Figure 8. Here, BECN1 is linked to neoplasm.